Instagram Linkedin Facebook-f
Appoinment

Research & Innovation

At 22Neuro, research is not an isolated activity—it is the heartbeat of our innovation.
 We combine AI, neuroscience, and clinical expertise to build technologies that don’t just treat neurological conditions, but anticipate them. Our R&D is shaped by a single belief: the future of healthcare lies in making the invisible workings of the brain visible, understandable, and actionable.

Our R&D Focus

We are positioned at the intersection of neurology, psychiatry, and data science. Our proprietary, cloud-based AI platform powers a wide range of research and clinical innovations:

  • Comparative & Progression Analysis: AI-driven algorithms track neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and stroke over time.
  • Multi-Parametric Data Integration: Combining imaging, EEG/QEEG signals, speech patterns, biomarkers, and clinical questionnaires into a single, holistic view of brain health.
  • Condition-Specific Pipelines: Tailored solutions for age-related cognitive decline, traumatic brain injury (TBI), and other neurological disorders.
  • Predictive Brain Health: Developing biomarkers and objective indicators to catch problems before they manifest clinically.
  • Our R&D ensures that technology evolves with the patient in mind—from prevention to long-term care.

Collaborations & Consortiums

Innovation thrives in partnership. 22Neuro collaborates with:

  • Academic Institutions to co-create advanced visualization tools and longitudinal datasets for predictive neurology.
  • Hospitals & Clinics to test and validate AI-driven diagnostics in real-world settings.
  • Global Research Networks across India, the US, EU, Australia, Korea, and the Middle East, ensuring diverse data and cross-border expertise.
  • Industry & Pharma Partners leveraging real-world data (RWD) for drug discovery and clinical trials.
  • Together, we are building an ecosystem of neuro-innovation that bridges the gap between discovery and delivery.

Patents & IP Portfolio

At 22Neuro, we don’t just innovate—we protect and scale innovation for long-term impact. Our intellectual property portfolio includes:

  • Proprietary algorithms for multi-modal brain data fusion.
  • Patents in AI-driven neuro navigation systems and digital biomarkers.
  • Breakthrough tools for longitudinal monitoring of neurodegenerative conditions.
  • Quantum-encrypted systems for secure patient data sharing.

These innovations strengthen our competitive edge while ensuring trust, security, and scalability.

Clinical Trials & Outcomes

Research at 22Neuro is constantly validated in real-world clinical settings.

  • AI-Powered Diagnostics Trials → proving faster, more accurate detection of stroke and cognitive disorders.
  • BrainVibe™ Pilot Programs → implemented in hospitals and enterprises to evaluate stress reduction and cognitive wellness outcomes.
  • Sleep & Circadian Studies → correlating lifestyle factors with neurological resilience.
  • Epilepsy & Stroke Navigation Trials → measuring patient recovery timelines with AI-assisted support.
Our outcomes demonstrate what we believe in: AI is not here to replace doctors—it’s here to empower them.

Insights for Academia

22Neuro actively contributes to the global knowledge pool through publications, whitepapers, and conference presentations.

  • Whitepapers on AI in Neurology and Predictive Brain Health.
  • Research contributions on biomarker development for dementia, epilepsy, and stroke.
  • Active participation in neurotech summits and academic symposiums, sharing insights on data-driven healthcare.

We see ourselves not only as innovators but as knowledge partners for the academic and clinical community.

 At 22Neuro, Research & Innovation is not just about technology—it’s about creating futures where brain health is predictable, preventable, and personalized.

Explore Partnerships with 22Neuro

Explore Partnerships with 22Neuro

Get in Touch

book appointment now